Related Experiment Video

Updated: Jun 12, 2026

Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates
06:49

Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates

Published on: May 8, 2020

DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer

Sarah L Allinson1

  • 1School of Health & Medicine, Division of Biomedical & Life Sciences, Lancaster University, Lancaster LA14YQ, UK. s.allinson@lancaster.ac.uk

Future Oncology (London, England)
|June 10, 2010
PubMed

Insights

Inhibiting the DNA repair enzyme polynucleotide kinase (PNK) can enhance cancer treatments. This approach shows promise for potentiating chemotherapy and radiotherapy by sensitizing cancer cells to DNA-damaging agents.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Development

Background:

  • DNA repair pathways are crucial for cancer cell survival.
  • Targeting DNA repair enzymes offers a strategy to enhance cancer therapies.
  • Polynucleotide kinase (PNK) is a key enzyme in DNA double-strand break repair.

Purpose of the Study:

  • To investigate the potential of pharmacological PNK inhibition for cancer treatment.
  • To evaluate PNK inhibitors as sensitizers to chemo- and radiotherapy.

Main Methods:

  • RNAi-mediated knockdown of PNK to assess cellular sensitization.
  • Development and testing of a small molecule PNK inhibitor.
  • Evaluation of PNK inhibition in combination with DNA-damaging agents like ionizing radiation and camptothecin.

Main Results:

  • RNAi-mediated PNK knockdown sensitized cells to various DNA-damaging agents.
  • A novel small molecule PNK inhibitor demonstrated sensitization to ionizing radiation and camptothecin.
  • PNK inhibition enhances the efficacy of DNA-damaging cancer therapies.

Conclusions:

  • Pharmacological inhibition of PNK is a promising strategy to potentiate chemo- and radiotherapy.
  • PNK inhibitors represent a novel approach to improve existing cancer treatment efficacy.
  • Further development of PNK inhibitors could lead to more effective cancer therapies.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...